Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model

Cancer Immunol Immunother. 2023 May;72(5):1183. doi: 10.1007/s00262-022-03342-x.

Tianyun Qiao^#^{1

2}, Jinbo Zhao^#², Xiangbing Xin^#², Yanlu Xiong², Wenwen Guo³, Fancheng Meng², Hui Li³, Yangbo Feng^{1

2}, Hui Xu⁴, Changhong Shi⁵, Yong Han⁶

¹ Department of Thoracic Surgery, Air Force Medical Center, Beijing, 100142, China.
² Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.
³ Laboratory Animal Center, Fourth Military Medical University, Xi'an, 710032, China.
⁴ School of Basic Medicine, Fourth Military Medical University, Xi'an, 710032, China. xubz@fmmu.edu.cn.
⁵ Laboratory Animal Center, Fourth Military Medical University, Xi'an, 710032, China. changhong@fmmu.edu.cn.
⁶ Department of Thoracic Surgery, Air Force Medical Center, Beijing, 100142, China. hanyong_td@163.com.

^# Contributed equally.

No abstract available

Publication types